Literature DB >> 11713277

Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway.

M W Wooten1, M L Vandenplas, M L Seibenhener, T Geetha, M T Diaz-Meco.   

Abstract

Atypical protein kinase C (PKC) isoforms are required for nerve growth factor (NGF)-initiated differentiation of PC12 cells. In the present study, we report that PKC-iota becomes tyrosine phosphorylated in the membrane coincident with activation posttreatment with nerve growth factor. Tyrosine phosphorylation and activation of PKC-iota were inhibited in a dose-dependent manner by both PP2 and K252a, src and TrkA kinase inhibitors. Purified src was observed to phosphorylate and activate PKC-iota in vitro. In PC12 cells deficient in src kinase activity, both NGF-induced tyrosine phosphorylation and activation of PKC-iota were also diminished. Furthermore, we demonstrate activation of src by NGF along with formation of a signal complex including the TrkA receptor, src, and PKC-iota. Recruitment of PKC-iota into the complex was dependent on the tyrosine phosphorylation state of PKC-iota. The association of src and PKC-iota was constitutive but was enhanced by NGF treatment, with the src homology 3 domain interacting with a PXXP sequence within the regulatory domain of PKC-iota (amino acids 98 to 114). Altogether, these findings support a role for src in regulation of PKC-iota. Tyrosine 256, 271, and 325 were identified as major sites phosphorylated by src in the catalytic domain. Y256F and Y271F mutations did not alter src-induced activation of PKC-iota, whereas the Y325F mutation significantly reduced src-induced activation of PKC-iota. The functional relevance of these mutations was tested by determining the ability of each mutant to support TRAF6 activation of NF-kappaB, with significant impairment by the Y325F PKC-iota mutant. Moreover, when the Y352F mutant was expressed in PC12 cells, NGF's ability to promote survival in serum-free media was reduced. In summary, we have identified a novel mechanism for NGF-induced activation of atypical PKC involving tyrosine phosphorylation by c-Src.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713277      PMCID: PMC100005          DOI: 10.1128/MCB.21.24.8414-8427.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

1.  Regulation of protein kinase Ctheta function during T cell activation by Lck-mediated tyrosine phosphorylation.

Authors:  Y Liu; S Witte; Y C Liu; M Doyle; C Elly; A Altman
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.

Authors:  B R Wong; D Besser; N Kim; J R Arron; M Vologodskaia; H Hanafusa; Y Choi
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

3.  Activation of protein kinase C delta by the c-Abl tyrosine kinase in response to ionizing radiation.

Authors:  Z M Yuan; T Utsugisawa; T Ishiko; S Nakada; Y Huang; S Kharbanda; R Weichselbaum; D Kufe
Journal:  Oncogene       Date:  1998-04-02       Impact factor: 9.867

4.  Protein kinase Ciota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis.

Authors:  L Jamieson; L Carpenter; T J Biden; A P Fields
Journal:  J Biol Chem       Date:  1999-02-12       Impact factor: 5.157

Review 5.  The extended protein kinase C superfamily.

Authors:  H Mellor; P J Parker
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

6.  Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha.

Authors:  Y Abu-Amer; F P Ross; K P McHugh; A Livolsi; J F Peyron; S L Teitelbaum
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

7.  Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling.

Authors:  S Ahn; S Maudsley; L M Luttrell; R J Lefkowitz; Y Daaka
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

8.  Protein kinase C delta (PKCdelta) inhibits the expression of glutamine synthetase in glial cells via the PKCdelta regulatory domain and its tyrosine phosphorylation.

Authors:  C Brodie; K Bogi; P Acs; P S Lorenzo; L Baskin; P M Blumberg
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

9.  Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-delta.

Authors:  J S Song; P G Swann; Z Szallasi; U Blank; P M Blumberg; J Rivera
Journal:  Oncogene       Date:  1998-07-02       Impact factor: 9.867

10.  An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3.

Authors:  Y Izumi; T Hirose; Y Tamai; S Hirai; Y Nagashima; T Fujimoto; Y Tabuse; K J Kemphues; S Ohno
Journal:  J Cell Biol       Date:  1998-10-05       Impact factor: 10.539

View more
  26 in total

Review 1.  Emerging and diverse roles of protein kinase C in immune cell signalling.

Authors:  Seng-Lai Tan; Peter J Parker
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

2.  A GAPDH mutant defective in Src-dependent tyrosine phosphorylation impedes Rab2-mediated events.

Authors:  Ellen J Tisdale; Cristina R Artalejo
Journal:  Traffic       Date:  2007-05-04       Impact factor: 6.215

3.  Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells.

Authors:  Elena M Rodriguez; Elizabeth E Dunham; G Steven Martin
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

Review 4.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

5.  Overexpression of atypical protein kinase C in HeLa cells facilitates macropinocytosis via Src activation.

Authors:  Ellen J Tisdale; Assia Shisheva; Cristina R Artalejo
Journal:  Cell Signal       Date:  2014-02-27       Impact factor: 4.315

Review 6.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

7.  Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration.

Authors:  W Tris Arscott; Anita T Tandle; Shuping Zhao; Jacob E Shabason; Ira K Gordon; Cody D Schlaff; Guofeng Zhang; Philip J Tofilon; Kevin A Camphausen
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

8.  Rapid axoglial signaling mediated by neuregulin and neurotrophic factors.

Authors:  Raymond M Esper; Jeffrey A Loeb
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

9.  Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells.

Authors:  Gabriella Castoria; Antimo Migliaccio; Marina Di Domenico; Maria Lombardi; Antonietta de Falco; Lilian Varricchio; Antonio Bilancio; Maria Vittoria Barone; Ferdinando Auricchio
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 10.  Extracellular vesicles shed by glioma cells: pathogenic role and clinical value.

Authors:  Dimitry A Chistiakov; Vladimir P Chekhonin
Journal:  Tumour Biol       Date:  2014-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.